Product Details

Dolutegravir (as Sodium)/ Lamivudine/Tenofovir Disoproxil Fumarate 50 mg/300 mg/300 mg Tablets

Dolutegravir (Dolutegravir Sodium); Lamivudine; Tenofovir Disoproxil Fumarate
50 mg; 300 mg; 300 mg
Tablet

ROA

Oral

Applicant Name

Phillips Pharmaceuticals (Nigeria) Limited

NRN

B4-9946

Status

Active


Composition

Each tablet contains: Dolutegravir (as Dolutegravir Sodium) 50 mg, Lamivudine 300 mg, Tenofovir Disoproxil Fumarate 300 mg  

ATC Code

 

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 30's, 1 x 90's  

Product Description

Tablet

Manufacturer Name

Cipla Limited

Manufacturer Country

INDIA  

Approval Date

2021-09-28  

Expiry Date

2026-09-27